The Enterprise Value as of November 2024 (TTM) for Leap Therapeutics, Inc. (LPTX) is 35.26M

According to Leap Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 35.26M. This represents a change of 41.16% compared to the average of 24.98M of the last 4 quarters.

Leap Therapeutics, Inc. (LPTX) Historical Enterprise Value (quarterly & annually)

How has LPTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Leap Therapeutics, Inc. over the last ten years is 61.38M. The current 35.26M Enterprise Value has changed 5.65% with respect to the historical average. Over the past ten years (40 quarters), LPTX's Enterprise Value was at its highest in in the December 2021 quarter at 252.02M. The Enterprise Value was at its lowest in in the March 2023 quarter at -57483948.20.

Leap Therapeutics, Inc. (LPTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Leap Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Leap Therapeutics, Inc. (LPTX) Average Enterprise Value

How has LPTX Enterprise Value performed in the past?

The current Enterprise Value of Leap Therapeutics, Inc. (LPTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Leap Therapeutics, Inc. (LPTX) Enterprise Value vs. Peers

How is LPTX’s Enterprise Value compared to its peers?

Leap Therapeutics, Inc.’s Enterprise Value is less than X4 Pharmaceuticals, Inc. (38.44M), less than Terns Pharmaceuticals, Inc. (222.97M), less than Day One Biopharmaceuticals, Inc. (963.46M), less than PDS Biotechnology Corporation (53.10M), less than Inozyme Pharma, Inc. (202.73M), greater than eFFECTOR Therapeutics, Inc. (4.74M), greater than Elevation Oncology, Inc. (18.49M), less than Mereo BioPharma Group plc (496.22M), greater than Hepion Pharmaceuticals, Inc. (5.35M), greater than HOOKIPA Pharma Inc. (-36166707.00), less than Acumen Pharmaceuticals, Inc. (139.19M),

Build a custom stock screener for Leap Therapeutics, Inc. (LPTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Leap Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Leap Therapeutics, Inc. (LPTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Leap Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.